Some reported reduction of FDG uptake could be used as a predictive marker for DFS, and FDG uptake for 2 cycles of NAC was associated with shorter event-free survival with ER +/HER2- breast cancer (Jung et al. 2010; Groheux et al. 2015). This evidence concerns the gene ERBB2 and breast carcinoma.